Briquilimab
JSP-CP-014
Phase 2 small_molecule active
Quick answer
Briquilimab for Urticaria Chronic is a Phase 2 program (small_molecule) at Jasper Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jasper Therapeutics
- Indication
- Urticaria Chronic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active